pseudomembranous colitis

Most cases of pseudomembranous colitis happen when a person is in the hospital, because the bacteria can spread from one patient to another.

People who have had pseudomembranous colitis should inform their doctors before taking antibiotics again.

In most cases, a patient presenting with pseudomembranous colitis has recently been on antibiotics.

However, a more serious form of diarrhea (pseudomembranous colitis) may rarely occur.

Metronidazole has on occasion been associated with the development of pseudomembranous colitis.

Two points were given for endoscopic evidence of pseudomembranous colitis or treatment in the intensive care unit.

As noted above, pseudomembranous colitis is characterized by diarrhea, abdominal pain, and fever.

Also, antibiotics can cause a disease called pseudomembranous colitis which results in severe, unrelenting diarrhea.

As with all antimicrobial agents, pseudomembranous colitis can occur during and up to several weeks after Azithromycin therapy.

Drugs used to stop diarrhea frequently worsen the course of C. difficile-related pseudomembranous colitis.

Several probiotic therapies have been used as adjunct therapies for pseudomembranous colitis.

A Clostridium difficile infection is the principal cause of ciprofloxacin-associated diarrhea and pseudomembranous colitis.

Pseudomembranous colitis: How useful is endoscopy?

During inflammation of the intestine (Pseudomembranous colitis), pseudomembranous tubes can be formed.

The spectrum of this disease ranges from asymptomatic carrier state to life-threatening pseudomembranous colitis and toxic megacolon.

Probiotic therapy of pseudomembranous colitis.

In fact, one of the main ways of distinguishing pseudomembranous colitis from other antibiotic-associated diarrheal states is that patients with the former are "sick".

Pseudomembranous colitis is a potentially lethal condition commonly associated with clindamycin, but which occurs with other antibiotics, as well.

Pseudomembranous colitis (caused by Clostridium difficile) has also developed in some patients; this condition may be fatal in a small number of cases.

The toxins function by damaging the intestinal mucosa and cause the symptoms of C. difficile infection, including pseudomembranous colitis.

Hepatitis, pseudomembranous colitis, psychotic reactions and Stevens-Johnson syndrome have also been associated with moxifloxacin therapy.

It is also possible that an infection persists but cannot be identified as was the case with pseudomembranous colitis when it was first treated in 1958.

Pseudomembranous colitis is infection of the large intestine (colon) with an overgrowth of Clostridium difficile bacteria.

It classically forms pseudomembranes and is often referred to as pseudomembranous colitis, which is its (non-specific) histomorphologic description.

The many different forms of colitis include cytomegalovirus or Cryptosporidium infection, and necrotizing and pseudomembranous colitis.